Proposed New Dynamic Prognostic Index for Diffuse Large B-Cell Lymphoma: International Metabolic Prognostic Index
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Proposed New Dynamic Prognostic Index for Diffuse Large B-Cell Lymphoma: International Metabolic Prognostic Index
Authors
Keywords
-
Journal
JOURNAL OF CLINICAL ONCOLOGY
Volume -, Issue -, Pages -
Publisher
American Society of Clinical Oncology (ASCO)
Online
2022-04-01
DOI
10.1200/jco.21.02063
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Optimal timing and criteria of interim PET in DLBCL: a comparative study of 1692 patients
- (2021) J. J. Eertink et al. Blood Advances
- 18F-FDG PET baseline radiomics features improve the prediction of treatment outcome in diffuse large B-cell lymphoma
- (2021) Jakoba J. Eertink et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- High total metabolic tumor volume at baseline allows discrimination of survival even in patients aged 60 to 80 years responding to R-CHOP
- (2020) Laetitia Vercellino et al. BLOOD
- International prognostic indices in diffuse large B-cell lymphoma (DLBCL): a comparison of IPI, R-IPI and NCCN-IPI
- (2020) Amy S Ruppert et al. BLOOD
- FDG-PET/CT after two cycles of R-CHOP in DLBCL predicts complete remission but has limited value in identifying patients with poor outcome - final result of a UK National Cancer Research Institute prospective study
- (2020) N. George Mikhaeel et al. BRITISH JOURNAL OF HAEMATOLOGY
- Rituximab-CHOP With Early Rituximab Intensification for Diffuse Large B-Cell Lymphoma: A Randomized Phase III Trial of the HOVON and the Nordic Lymphoma Group (HOVON-84)
- (2020) Pieternella Johanna Lugtenburg et al. JOURNAL OF CLINICAL ONCOLOGY
- Automated segmentation of baseline metabolic total tumor burden in diffuse large B-cell lymphoma: which method is most successful ?
- (2020) Sally F Barrington et al. JOURNAL OF NUCLEAR MEDICINE
- Time to prepare for risk adaptation in lymphoma by standardising measurement of metabolic tumour burden
- (2019) Sally F. Barrington et al. JOURNAL OF NUCLEAR MEDICINE
- 18F-FDG-PET dissemination features in diffuse large B cell lymphoma are prognostic of outcome
- (2019) Anne-Segolene Cottereau et al. JOURNAL OF NUCLEAR MEDICINE
- Dynamic risk assessment based on positron emission tomography scanning in diffuse large B-cell lymphoma: Post-hoc analysis from the PETAL trial
- (2019) Christine Schmitz et al. EUROPEAN JOURNAL OF CANCER
- Prognostic value of baseline metabolic tumor volume in early-stage Hodgkin lymphoma in the standard arm of the H10 trial
- (2018) Anne-Ségolène Cottereau et al. BLOOD
- Defining the optimal method for measuring baseline metabolic tumour volume in diffuse large B cell lymphoma
- (2018) Hajira Ilyas et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Positron Emission Tomography–Guided Therapy of Aggressive Non-Hodgkin Lymphomas (PETAL): A Multicenter, Randomized Phase III Trial
- (2018) Ulrich Dührsen et al. JOURNAL OF CLINICAL ONCOLOGY
- Does PET Reconstruction Method Affect Deauville Scoring in Lymphoma Patients?
- (2018) Ronald Boellaard et al. JOURNAL OF NUCLEAR MEDICINE
- Effect of PET/CT on the Management and Outcomes of Participants with Hodgkin and Aggressive Non-Hodgkin Lymphoma: A Multicenter Registry
- (2018) Ur Metser et al. RADIOLOGY
- Predictive Value of PET Response Combined with Baseline Metabolic Tumor Volume in Peripheral T-Cell Lymphoma Patients
- (2017) Anne-Ségolène Cottereau et al. JOURNAL OF NUCLEAR MEDICINE
- Prognostic value of baseline total metabolic tumor volume (TMTV0) measured on FDG-PET/CT in patients with peripheral T-cell lymphoma (PTCL)
- (2016) A. S. Cottereau et al. ANNALS OF ONCOLOGY
- Combination of baseline metabolic tumour volume and early response on PET/CT improves progression-free survival prediction in DLBCL
- (2016) N. George Mikhaeel et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Baseline Metabolic Tumor Volume Predicts Outcome in High–Tumor-Burden Follicular Lymphoma: A Pooled Analysis of Three Multicenter Studies
- (2016) Michel Meignan et al. JOURNAL OF CLINICAL ONCOLOGY
- Final Results of a Prospective Evaluation of the Predictive Value of Interim Positron Emission Tomography in Patients With Diffuse Large B-Cell Lymphoma Treated With R-CHOP-14 (SAKK 38/07)
- (2015) Christoph Mamot et al. JOURNAL OF CLINICAL ONCOLOGY
- A clinically based prognostic index for diffuse large B-cell lymphoma with a cut-off at 70 years of age significantly improves prognostic stratification: population-based analysis from the Danish Lymphoma Registry
- (2015) Anne O. Gang et al. LEUKEMIA & LYMPHOMA
- Is 70 the new 60? New international prognostic index with an older age cut-off for diffuse large B-cell lymphoma
- (2015) N. George Mikhaeel LEUKEMIA & LYMPHOMA
- Diffuse large B-cell lymphoma: optimizing outcome in the context of clinical and biologic heterogeneity
- (2014) Laurie H. Sehn et al. BLOOD
- Pretherapy metabolic tumour volume is an independent predictor of outcome in patients with diffuse large B-cell lymphoma
- (2014) Myriam Sasanelli et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Recommendations for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The Lugano Classification
- (2014) Bruce D. Cheson et al. JOURNAL OF CLINICAL ONCOLOGY
- An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era
- (2013) Z. Zhou et al. BLOOD
- A framework for developing, implementing, and evaluating clinical prediction models in an individual participant data meta-analysis
- (2013) Thomas P.A. Debray et al. STATISTICS IN MEDICINE
- Clinical significance of metabolic tumor volume by PET/CT in stages II and III of diffuse large B cell lymphoma without extranodal site involvement
- (2011) Moo-Kon Song et al. ANNALS OF HEMATOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More